Cleveland BioLabs, Inc. Recorded Big Gain
Tue, Oct 20, 2020 at 05:30 PM
Cleveland BioLabs, Inc. (CBLI:NASDAQ) soared at $3.17, a gain of 46.1%. On Mon 19 Oct 20, CBLI:NASDAQ touched a New 2-Week Intraday High of $2.5. The stock got featured on our News Catalysts scanner on Tue 20 Oct 20 at 03:34 PM in the 'MERGER' category. From Mon 05 Oct 20, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Fri 26 Jun 20 at $4.43 with a volume of 51M+, and its share price has been moving sideways in recent weeks.
About Cleveland BioLabs, Inc. (CBLI:NASDAQ)
Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.
Top 10 Gainers:
- Weidai Ltd. (WEI:NYSE), 526.45%
- X Financial (XYF:NYSE), 75.88%
- Dragon Victory International Limited (LYL:NASDAQ), 47.64%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 46.08%
- Jupai Holdings Limited (JP:NYSE), 42.69%
- Molecular Data Inc. (MKD:NASDAQ), 41.82%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 39.42%
- China Index Holdings Limited (CIH:NASDAQ), 35.71%
- Iterum Therapeutics plc (ITRM:NASDAQ), 35.29%
- Drive Shack Inc. (DS:NYSE), 31.62%